Table 1.
Clinical and epidemiological characteristics for the study cohort of 1,911 patients with cirrhosis.
| Characteristic | n (%) |
|---|---|
| Age, mean±SD | 59.56±10.02 |
| Gender | |
| Female | 682 (35.69%) |
| Male | 1229 (64.31%) |
| Race and ethnicity | |
| NH-White | 963 (50.39%) |
| NH-Black | 350 (18.32%) |
| Hispanic | 548 (28.68%) |
| Others | 50 (2.62%) |
| Smoking | |
| Never | 778 (40.71%) |
| Former | 734 (38.41%) |
| Current | 391 (20.46%) |
| Missing | 8 (0.42%) |
| Current heavy alcohol use | |
| No | 1785 (93.41%) |
| Yes | 118 (6.17%) |
| Missing | 8 (0.42%) |
| Hypertension | |
| No | 938 (49.08%) |
| Yes | 973 (50.92%) |
| Dyslipidemia | |
| No | 1252 (65.52%) |
| Yes | 659 (34.48%) |
| Diabetes | |
| No | 1076 (56.31%) |
| Yes | 835 (43.69%) |
| Obesity | |
| No (BMI<30) | 933 (48.82%) |
| Yes (BMI>=30) | 973 (50.92%) |
| Missing | 5 (0.26%) |
| Cirrhosis Etiology | |
| Alcohol-related | 320 (16.75%) |
| Autoimmune | 143 (7.48%) |
| Hepatitis C active | 255 (13.34%) |
| Hepatitis C cured | 513 (26.84%) |
| Hepatitis B chronic | 31 (1.62%) |
| MASLD | 591 (30.93%) |
| Others | 58 (3.04%) |
| PNPLA3, rs738409 | |
| Noncarrier [0] | 795 (41.6%) |
| Carrier [1, 2] | 1116 (58.4%) |